We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$11.9B
AUM Growth
+$1.4B
Cap. Flow
+$748M
Cap. Flow %
6.3%
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$134M
2
STM icon
STMicroelectronics
STM
+$103M
3
META icon
Meta Platforms (Facebook)
META
+$89.9M
4
MET icon
MetLife
MET
+$71.9M
5
GILD icon
Gilead Sciences
GILD
+$70.3M

Top Sells

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$161M
2
LLY icon
Eli Lilly
LLY
+$153M
3
MRSH
Marsh
MRSH
+$123M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$91.8M
5
EA icon
Electronic Arts
EA
+$79.5M

Sector Composition

Rank Sector Weight
1 Healthcare 43.43%
2 Technology 17.4%
3 Industrials 8.07%
4 Energy 6.4%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DV icon
526
DoubleVerify
DV
$1.84B
$707K 0.01%
+42,012
New +$801K
MGNX icon
527
MacroGenics
MGNX
$248M
$621K 0.01%
188,711
-180,831
-49% -$704K
ATAI icon
528
AtaiBeckley Inc
ATAI
$2.67B
$621K 0.01%
+535,047
New +$713K
MKSI icon
529
MKS Inc
MKSI
$21.1B
$605K 0.01%
+5,567
New +$661K
AMBA icon
530
Ambarella
AMBA
$3.59B
$602K 0.01%
10,674
-63,000
-86% -$3.35M
AME icon
531
Ametek
AME
$58.4B
$595K 0.01%
+3,468
New +$579K
AI icon
532
C3.ai
AI
$1.54B
$545K ﹤0.01%
22,506
-3,922
-15% -$99.7K
TCRX icon
533
TScan Therapeutics
TCRX
$51M
$541K ﹤0.01%
108,584
-54,908
-34% -$331K
BASE
534
DELISTED
Couchbase
BASE
$530K ﹤0.01%
+32,864
New +$569K
WIX icon
535
WIX.com
WIX
$2.7B
$497K ﹤0.01%
2,973
-1,206
-29% -$194K
SLP icon
536
Simulations Plus
SLP
$371M
$495K ﹤0.01%
+15,454
New +$571K
SLAB icon
537
Silicon Laboratories
SLAB
$7.2B
$495K ﹤0.01%
4,280
-77,606
-95% -$8.66M
VIGL
538
DELISTED
Vigil Neuroscience
VIGL
$490K ﹤0.01%
144,142
-62,472
-30% -$231K
RAPT
539
DELISTED
RAPT Therapeutics
RAPT
$476K ﹤0.01%
29,624
+8,876
+43% +$180K
CRTO icon
540
Criteo S.A. Ordinary Shares
CRTO
$857M
$473K ﹤0.01%
11,748
+3,044
+35% +$134K
BRZE icon
541
Braze
BRZE
$2.95B
$466K ﹤0.01%
14,421
-19,752
-58% -$780K
CTMX icon
542
CytomX Therapeutics
CTMX
$723M
$465K ﹤0.01%
+393,832
New +$500K
NTCT icon
543
NETSCOUT
NTCT
$2.98B
$460K ﹤0.01%
+21,165
New +$417K
OUT icon
544
Outfront Media
OUT
$5.64B
$460K ﹤0.01%
+25,399
New +$403K
TKO icon
545
TKO Group
TKO
$13.4B
$451K ﹤0.01%
3,644
AMZN icon
546
Amazon
AMZN
$2.94T
$428K ﹤0.01%
2,296
-189,540
-99% -$34.6M
LOGI icon
547
Logitech
LOGI
$15.1B
$425K ﹤0.01%
+4,735
New +$421K
APPF icon
548
AppFolio
APPF
$6.84B
$401K ﹤0.01%
+1,704
New +$399K
ETNB
549
DELISTED
89bio
ETNB
$395K ﹤0.01%
+53,347
New +$449K
VERX icon
550
Vertex
VERX
$1.91B
$365K ﹤0.01%
+9,490
New +$350K

Similar funds

Woodline Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.

  • Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
  • Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
  • Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
  • Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
  • Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
  • Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
  • Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.

Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.